beta-lapachone has been researched along with Inflammation in 4 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammatory diseases such as bacterial diseases, Alzheimer's disease, rheumatoid arthritis, multiple sclerosis, and so on, impose huge costs on the health systems." | 2.66 | An evaluation on potential anti-inflammatory effects of β-lapachone. ( Fathi Maroufi, N; Karimi, P; Kazemzadeh, H; Mokarizadeh, N; Nikanfar, S; Rashtchizadeh, N; Sadigh-Eteghad, S, 2020) |
| "Sepsis is characterized by a dysregulated immune response to infection characterized by an early hyperinflammatory and oxidative response followed by a subsequent immunosuppression phase." | 1.56 | ( de A Pontes, ACA; de B Oliveira, AL; de Oliveira, AB; de Oliveira, JP; Dorneles, GP; Dos Santos, SM; Júnior, LCR; Monteiro, MC; Monteiro, VVS; Navegantes-Lima, KC; Quadros, LBG; Romão, PRT, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mokarizadeh, N | 1 |
| Karimi, P | 1 |
| Kazemzadeh, H | 1 |
| Fathi Maroufi, N | 1 |
| Sadigh-Eteghad, S | 1 |
| Nikanfar, S | 1 |
| Rashtchizadeh, N | 1 |
| de B Oliveira, AL | 1 |
| Navegantes-Lima, KC | 1 |
| Monteiro, VVS | 1 |
| Quadros, LBG | 1 |
| de Oliveira, JP | 1 |
| Dos Santos, SM | 1 |
| de A Pontes, ACA | 1 |
| Dorneles, GP | 1 |
| Romão, PRT | 1 |
| Júnior, LCR | 1 |
| de Oliveira, AB | 1 |
| Monteiro, MC | 1 |
| Kim, YH | 1 |
| Hwang, JH | 1 |
| Noh, JR | 1 |
| Gang, GT | 1 |
| Tadi, S | 1 |
| Yim, YH | 1 |
| Jeoung, NH | 1 |
| Kwak, TH | 1 |
| Lee, SH | 1 |
| Kweon, GR | 1 |
| Kim, JM | 1 |
| Shong, M | 1 |
| Lee, IK | 1 |
| Lee, CH | 1 |
| Tzeng, HP | 1 |
| Ho, FM | 1 |
| Chao, KF | 1 |
| Kuo, ML | 1 |
| Lin-Shiau, SY | 1 |
| Liu, SH | 1 |
1 review available for beta-lapachone and Inflammation
| Article | Year |
|---|---|
An evaluation on potential anti-inflammatory effects of β-lapachone.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bacterial Infections; H | 2020 |
3 other studies available for beta-lapachone and Inflammation
| Article | Year |
|---|---|
Topics: Animals; Anti-Inflammatory Agents; Chemoprevention; Cytokines; Disease Models, Animal; Immunosuppres | 2020 |
Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase.
Topics: Acute Kidney Injury; Animals; Apoptosis; Enzyme Activation; Enzyme Activators; Fibrosis; Inflammatio | 2012 |
beta-Lapachone reduces endotoxin-induced macrophage activation and lung edema and mortality.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinica | 2003 |